Open AccessLow Voltage Vagal Nerve Stimulation Reduces Bronchoconstriction in Guinea Pigs Through Catecholamine Release
Author(s) -
Hoffmann Thomas J.,
Simon Bruce J.,
Zhang Yi,
Emala Charles W.
Publication year - 2012
Publication title -
neuromodulation: technology at the neural interface
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.296
H-Index - 60
eISSN - 1525-1403
pISSN - 1094-7159
DOI - 10.1111/j.1525-1403.2012.00454.x
Subject(s) - bronchoconstriction , stimulation , catecholamine , anesthesia , medicine , nerve stimulation , guinea pig , vagus nerve , airway
Objective: Electrical stimulation of the vagus nerve at relatively high voltages (e.g., >10 V) can induce bronchoconstriction. However, low voltage (≤2 V) vagus nerve stimulation (VNS) can attenuate histamine‐invoked bronchoconstriction. Here, we identify the mechanism for this inhibition. Methods: In urethanea‐nesthetized guinea pigs, bipolar electrodes were attached to both vagus nerves and changes in pulmonary inflation pressure were recorded in response to i.v. histamine and during VNS. The attenuation of the histamine response by low‐voltage VNS was then examined in the presence of pharmacologic inhibitors or nerve ligation. Results: Low‐voltage VNS attenuated histamine‐induced bronchoconstriction (4.4 ± 0.3 vs. 3.2 ± 0.2 cm H 2 O, p < 0.01) and remained effective following administration of a nitric oxide synthase inhibitor, NG‐nitro‐L‐arginine methyl ester, and after sympathetic nerve depletion with guanethidine, but not after the β‐adrenoceptor antagonist propranolol. Nerve ligation caudal to the electrodes did not block the inhibition but cephalic nerve ligation did. Low‐voltage VNS increased circulating epinephrine and norepinephrine without but not with cephalic nerve ligation. Conclusion: These results indicate that low‐voltage VNS attenuates histamine‐induced bronchoconstriction via activation of afferent nerves, resulting in a systemic increase in catecholamines likely arising from the adrenal medulla.